Fold change in CD3+CD8+T cells (left) and CD3+CD8+GZMB+ T cells (right) at C2D16 compared to screening, between patients with low or high levels of TIL at baseline using the median as threshold at screening. pvalue was determined by an unpaired two-sided Wilcoxon test.
